Hiram A. Ruiz-Santiago

Dermatology

Bayamon, PR 00959

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.

Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.

Journal: Dermatology and therapy

Published: February 13, 2026

Showing 1-1 of 1

Last Updated: 09/26/2026